However, the detailed molecular mechanisms by which LOC401317 inhibits NPC cell growth, how LOC401317 regulates downstream p53 signaling pathways, and how LOC401317 expression in NPC samples correlates with the prognosis of NPC patients remain unclear and will be the focus of prospective studies. Here, TP53 is linked to nasopharyngeal carcinoma.